Cabaletta Bio (CABA) Operating Expenses (2018 - 2025)

Cabaletta Bio's Operating Expenses history runs 8 years deep, the most recent figure standing at $42.6 million for Q4 2025.

• On a quarterly basis, Operating Expenses rose 26.12% year-over-year to $42.6 million in Q4 2025; TTM through Dec 2025 was $172.2 million, a 37.64% increase from a year earlier, with the FY2025 full-year figure at $172.2 million, up 37.64% from the prior year.
• Operating Expenses fell to $42.6 million in Q4 2025 per CABA's latest filing, from $46.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $46.6 million in Q3 2025 and bottomed at $9.7 million in Q1 2021.
• The 5-year median for Operating Expenses is $17.8 million (2023), against an average of $23.6 million.
• Across the five-year window, Operating Expenses increased 1.86% in 2022 and surged 90.55% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $13.9 million in 2021, then rose by 17.34% to $16.3 million in 2022, then soared by 41.98% to $23.1 million in 2023, then surged by 45.96% to $33.8 million in 2024, then advanced by 26.12% to $42.6 million in 2025.
• Per Business Quant, the three latest CABA Operating Expenses figures stand at $42.6 million (Q4 2025), $46.6 million (Q3 2025), and $45.9 million (Q2 2025).